PET-CT pp 269-288 | Cite as

Myocardial Viability

  • Shahram Bonyadlou
  • Sindu Sheth

Abstract

Cases showing various presentations of myocardial viability.

Keywords

Sugar Catheter Ischemia Attenuation Hydrocortisone 

Suggested Reading

  1. Abraham A, Nihhol G, Williams KA, et al. F-18-FDG PET imaging of myocardial viability in an experienced center with access to F-18-FDG and integration with clinical management teams: the Ottawa-FIVE sub study of the PARR 2 Trial. J Nucl Med. 2010;51:567–74.CrossRefPubMedGoogle Scholar
  2. Bax JJ, Veening MA, Visser FC, et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging: A comparative study using different protocols. Eur J Nucl Med. 1997;24:35–41.CrossRefPubMedGoogle Scholar
  3. Bax JJ, Visser FC, Poldermans D, et al. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinemic-euglycemic clamping. Eur J Nucl Med. 2002;29:452–7.CrossRefGoogle Scholar
  4. Brix G, Lechel U, Glatting G, et al. Radiation exposure of patients undergoing whole-body dual-modality F-18 PET/Ct examinations. J Nucl Med. 2005;46:608–13.PubMedGoogle Scholar
  5. Brogsitter C, Gruning T, Weise R, et al. F-18-FDG PET for detecting myocardial viability: validation of 3D data acquisition. J Nucl Med. 2005;46:19–24.PubMedGoogle Scholar
  6. Di Carli MF, Murthy VL. Cardiac PET/CT for the evaluation of known or suspected coronary artery disease. Radiographics. 2011;31(5):1239–54.CrossRefPubMedCentralPubMedGoogle Scholar
  7. Eckerman KF, Endo A, editors. MIRD: radionuclide data and decay schemes. Reston: Society of Nuclear Medicine; 2008. p. 52.Google Scholar
  8. Fukuchi K, Ohta H, Matsumura K, et al. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol. 2007;80(949):3–11. Epub 2006 Sep 27.CrossRefPubMedGoogle Scholar
  9. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med. 1990;31:1899–905.PubMedGoogle Scholar
  10. Hays MT, Watson EE, Thomas SR, et al. MIRD dose estimate report no. 19: radiation absorbed dose estimates from F-18-FDG. J Nucl Med. 2002;43:210–4.PubMedGoogle Scholar
  11. Hernandez-Pampaloni M, Bax JJ, Morita K, et al. Incidence of stunned, hibernation and scarred myocardium in ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2005;32:314–21.CrossRefPubMedGoogle Scholar
  12. Huitink JM, Visser FC, van Leeuwen GR, et al. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging. Eur J Nucl Med. 1995;22:1141–8.CrossRefPubMedGoogle Scholar
  13. Langah R, Spicer K, Gebregzlabher M, et al. Effectiveness of prolonged fasting F-18-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol. 2009;16: 801–10.CrossRefPubMedGoogle Scholar
  14. Lehman SJ, Abbara S, Cury RC, et al. Significance of cardiac computed tomography incidental findings in acute chest pain. Am J Med. 2009;122(6):543–9.CrossRefPubMedGoogle Scholar
  15. Lewis P, Nunan T, Dynes A, et al. The use of low-dose intravenous insulin in myocardial F-18 FDG PET scanning. Clin Nucl Med. 1996;21:15–8.CrossRefPubMedGoogle Scholar
  16. Loghin C, Sdringola S, Gould KL. Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions. J Nucl Med. 2004;45(6):1029–39.PubMedGoogle Scholar
  17. Martin WH, Jones RC, Delbeke D, et al. A simplified intravenous glucose loading protocol for fluorine-18-florodeoxyglucose cardiac single-photon emission tomography. Eur J Nucl Med. 1997;24:1291–7.CrossRefPubMedGoogle Scholar
  18. Martinez-Möller A, Souvatzoglou M, Navab N, et al. Artifacts from misaligned CT in cardiac perfusion PET/CT studies: frequency, effects, and potential solutions. J Nucl Med. 2007;48(2):188–93.PubMedGoogle Scholar
  19. Matsunari I, Kanayama S, Yoneyama T, et al. Myocardial distribution of F-18-FDG and Tc-99m-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET. Eur J Nucl Med. 2002;29:1357–64.CrossRefGoogle Scholar
  20. Mesotten L, Maes A, Van de Werf F, et al. PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey. Eur J Nucl Med. 2002;29:3–6.CrossRefGoogle Scholar
  21. Metrard G, Girault S, Capitain O, et al. Uncommon breast tumor attenuation artifact on radionuclide ventriculography. Clin Nucl Med. 2008;33(4):288–9.CrossRefPubMedGoogle Scholar
  22. Mettler FA, Bhargavan M, Thomadsen BR, et al. Nuclear medicine exposure in the United states, 2005–2007: preliminary results. Semin Nucl Med. 2008;38:384–91.CrossRefPubMedGoogle Scholar
  23. Mirpour S, Khandani AH. Extracardiac abnormalities on rubidium-82 cardiac positron emission tomography/computed tomography. Nucl Med Commun. 2011;32(4):260–4.CrossRefPubMedGoogle Scholar
  24. Mueller J, Jeudy J, Poston R, et al. Cardiac CT angiography after coronary bypass surgery: prevalence of incidental findings. Am J Roentgenol. 2007;189(2):414–9.CrossRefGoogle Scholar
  25. Nye JA, Esteves F, Votaw JR. Minimizing artifacts resulting from respiratory and cardiac motion by optimization of the transmission scan in cardiac PET/CT. Med Phys. 2007;34(6):1901–6.CrossRefPubMedGoogle Scholar
  26. Sandler MP, Bax JJ, Patton JA, et al. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera. J Nucl Med. 1998;39:2035–43.PubMedGoogle Scholar
  27. Schelbert HR. F-18-deoxyglucose and the assessment of myocardial viability. Sem Nucl Med. 2002;32:60–9.CrossRefGoogle Scholar
  28. Schinkel AFL, Bax JJ, Valkema R, et al. Effect of diabetes mellitus on myocardial F-18-FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med. 2003;44:877–83.PubMedGoogle Scholar
  29. Stankewicz MA, Mansouir CS, Eisner RL, et al. Myocardial viability assessment by PET: Rb-82 defect washout does not predict the results of metabolic-perfusion mismatch. J Nucl Med. 2005;46:1602–9.PubMedGoogle Scholar
  30. Stewart RE, Schwaiger M, Molina E, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol. 1991;67:1303–10.CrossRefPubMedGoogle Scholar
  31. Stone CK, Holden JE, Stanley W, et al. Effect of nicotinic acid on exogenous myocardial glucose utilization. J Nucl Med. 1995;36:996–1002.PubMedGoogle Scholar
  32. Van Campen CMC, Viser FC, van der Weerdt AP, et al. FDG PET as a predictor of response to resynchronization therapy in patients with ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2007;34:309–15.CrossRefPubMedGoogle Scholar
  33. Waxman AD, Barondess P. Preparing patients for PET imaging: the importance of prescan communication. Discussion in PET Imaging. New York: CMP Healthcare Media; 2004.Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Shahram Bonyadlou
    • 1
  • Sindu Sheth
    • 2
  1. 1.Department of Radiology, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA
  2. 2.Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations